Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal
Abstract
This study analysed the spectrum, antifungal susceptibility pattern, clinical course and molecular epidemiology of cryptococcosis. Four hundred and thirty-nine samples obtained from 378 meningitis patients were processed by standard procedures. Minimum inhibitory concentration (MIC) of fluconazole and amphotericin B for the isolates was tested by broth micro dilution and by E-strip method. Molecular analysis by random amplified polymorphic DNA-PCR of eight isolates was performed using M13 primer. Cryptococcosis was diagnosed in 35 patients [HIV-1 seropositive (19) and apparently immunocompetent (16)]. Cryptococcus neoformans var. neoformans (serotype A and D) was the predominant isolate on phenotypic identification. Three C. neoformans var. gattii were isolated from HIV-1 seropositive (2) and apparently immunocompetent (1) patients. MIC 90 for amphotericin B and fluconazole were 1 and 8 mug ml(-1) respectively. On RAPD-PCR, less diversity was seen among Indian isolates. AIDS remains the single most important risk factor for cryptococcosis. Rising MIC of the available induction and maintenance drugs is of grave concern. The DNA typing technique showed less diversity among Indian strains. Routine surveillance and application of molecular typing methods are crucial to know the baseline and existing pattern of cryptococcosis.Keywords
This publication has 24 references indexed in Scilit:
- Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with CryptococcosisAntimicrobial Agents and Chemotherapy, 2006
- Cryptococcosis in apparently immunocompetent patientsQJM: An International Journal of Medicine, 2006
- Clinical and radiographic presentations of pulmonary cryptococcosis in immunocompetent patientsScandinavian Journal of Infectious Diseases, 2006
- Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from IndiaJournal of Clinical Microbiology, 2005
- Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathologyJournal of Medical Microbiology, 2004
- Cryptococcus Infection in Tropical AustraliaJournal of Clinical Microbiology, 2004
- Molecular epidemiology ofCryptococcusneoformansisolates from AIDS patients of the Brazilian city, Rio de JaneiroMedical Mycology, 2004
- Fluconazole and itraconazole susceptibility ofclinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for careJournal of Antimicrobial Chemotherapy, 2003
- The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000Clinical Infectious Diseases, 2003
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998Antimicrobial Agents and Chemotherapy, 2001